1. Home
  2. THM vs JANX Comparison

THM vs JANX Comparison

Compare THM & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$2.57

Market Cap

723.2M

Sector

N/A

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.58

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THM
JANX
Founded
1978
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.2M
790.3M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
THM
JANX
Price
$2.57
$13.58
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$53.60
AVG Volume (30 Days)
1.6M
784.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$209.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$12.12
52 Week High
$3.65
$35.34

Technical Indicators

Market Signals
Indicator
THM
JANX
Relative Strength Index (RSI) 41.87 46.12
Support Level $2.17 $13.01
Resistance Level $3.63 $13.79
Average True Range (ATR) 0.28 0.55
MACD -0.08 0.07
Stochastic Oscillator 3.13 37.58

Price Performance

Historical Comparison
THM
JANX

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: